Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) EPS (Weighted Average and Diluted) (2024 - 2025)

Historic EPS (Weighted Average and Diluted) for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to -$0.35.

  • Pyxis Oncology's EPS (Weighted Average and Diluted) changed 0.0% to -$0.35 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.59, marking a year-over-year change of. This contributed to the annual value of -$1.32 for FY2024, which is 2847.98% up from last year.
  • Latest data reveals that Pyxis Oncology reported EPS (Weighted Average and Diluted) of -$0.35 as of Q3 2025, which was down 0.0% from -$0.3 recorded in Q2 2025.
  • Over the past 5 years, Pyxis Oncology's EPS (Weighted Average and Diluted) peaked at -$0.06 during Q1 2024, and registered a low of -$0.61 during Q4 2024.